JW Therapeutics to raise $20 million in share placement at 3% discount
Cell immunotherapy biotechnology company JW (Cayman) Therapeutics Co. Ltd. (2126.HK) said on Sunday it plans to issue 61.19 million new shares to two institutional investors at a subscription price of…
2126.HK
Recent Articles
RELATED ARTICLES
- Quantgroup to raise $20.7 million in share placement at 15% discount
- Zhida to raise $26 million through share placement at 12% discount
- CStone’s CS2009 trispecific antibody reinforces three clinical validations at ESMO
-
Nuobikan seeks $17 million in share placement at 13.6% discount
2635.HK
-
Xunzhong raises $46.8 million through share placement at 19% discount
2597.HK
- BRIEF: Unisound launches third share placement this year to raise $48.6 million
- MMG to raise $1.6 billion through share placement and convertible bonds
Discover hidden China stock gems in our weekly newsletter